Pfizer-BioNTech agree to supply WHO co-led Covid-19 vaccine scheme: Report
Pfizer and BioNTech have agreed to supply their Covid-19 vaccine to the World Health Organization co-led COVAX vaccine access scheme, two
sources familiar with the deal said, the latest in a series of shots to be
included in the project aimed at lower-income countries.
The deal
is expected to be announced on Friday, according to the sources, who declined
to be named due to the confidentiality of the agreement.
Details
on the size of the deal or the price per dose COVAX would pay were not
immediately clear, but the sources said the allotment would likely be
relatively small. One source said the reason for the limited volume was that
the doses were primarily meant for healthcare workers in the countries that
COVAX serves.
BioNTech declined to comment
while Pfizer did not respond to requests for comment. Spokespeople for the WHO
and the GAVI vaccine alliance, which co-leads the COVAX scheme, also declined
to comment. Read More
Comments
Post a Comment